$AXON
AXON ENTERPRISE, INC. Stock $axon

$axon Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000155837023002413 Filed on February 28, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$343.0M	$336.1M	$1.190B
YoY Change	33.78%	54.49%	37.82%
Cost Of Revenue	$138.9M	$130.5M	$461.3M
YoY Change	37.99%	58.1%	43.05%
Gross Profit	$204.1M	$205.7M	$728.6M
YoY Change	31.05%	52.29%	34.71%
Gross Profit Margin	59.5%	61.19%	61.23%
Selling, General & Admin	$116.6M	$114.4M	$401.6M
YoY Change	29.33%	2.66%	-22.03%
% of Gross Profit	57.11%	55.63%	55.11%
Research & Development	$70.93M	$68.72M	$233.8M
YoY Change	46.49%	35.61%	20.5%
% of Gross Profit	34.75%	33.41%	32.09%
Depreciation & Amortization	$6.689M	$6.210M	$24.38M
YoY Change	16.23%	17.75%	30.42%
% of Gross Profit	3.28%	3.02%	3.35%
Operating Expenses	$187.5M	$183.1M	$635.4M
YoY Change	35.33%	12.96%	-10.39%
Operating Profit	$16.61M	$22.54M	$93.25M
YoY Change	-3.41%	-183.28%	-155.47%
Interest Expense	$25.28M	$12.19M	$103.3M
YoY Change	-54.29%	-220.11%	286.07%
% of Operating Profit	152.19%	54.07%	110.74%
Other Income/Expense, Net	$15.61M		$98.97M
YoY Change			291.73%
Pretax Income	$41.88M	$34.73M	$196.5M
YoY Change	-42.22%	-193.33%	-239.0%
Income Tax	-$3.255M	$5.555M	$49.38M
% Of Pretax Income	-7.77%	15.99%	25.13%
Net Earnings	$45.14M	$29.18M	$147.1M
YoY Change	-17.74%	-315.98%	-345.16%
Net Earnings / Revenue	13.16%	8.68%	12.37%
Basic Earnings Per Share	$0.62		$2.07
Diluted Earnings Per Share	$0.61	$0.40	$2.03
COMMON SHARES
Basic Shares Outstanding	72.86M	71.17M	71.09M
Diluted Shares Outstanding	73.88M		72.53M

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$318.2M	$392.9M	$974.7M
YoY Change	-28.32%	-8.31%	120.01%
Cash & Equivalents	$263.4M	$353.7M	$353.7M
Short-Term Investments	$54.81M	$39.24M	$621.0M
Other Short-Term Assets	$142.3M	$73.02M	$73.02M
YoY Change	111.76%	29.15%	29.15%
Inventory	$220.3M	$202.5M	$202.5M
Prepaid Expenses
Receivables	$596.8M	$555.1M	$555.1M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.053B	$1.805B	$1.805B
YoY Change	79.1%	62.71%	62.71%
LONG-TERM ASSETS
Property, Plant & Equipment	$172.7M	$169.8M	$208.2M
YoY Change	15.5%	22.67%	28.74%
Goodwill	$44.98M	$44.98M
YoY Change	3.15%	3.19%
Intangibles	$11.27M	$12.16M
YoY Change	-21.73%	-21.41%
Long-Term Investments	$327.7M	$452.8M	$452.8M
YoY Change	90.31%	294.56%	294.56%
Other Assets	$168.2M	$159.6M	$278.1M
YoY Change	71.6%	62.46%	37.56%
Total Long-Term Assets	$955.3M	$1.047B	$1.047B
YoY Change	52.51%	80.85%	80.85%
TOTAL ASSETS
Total Short-Term Assets	$2.053B	$1.805B	$1.805B
Total Long-Term Assets	$955.3M	$1.047B	$1.047B
Total Assets	$3.008B	$2.852B	$2.852B
YoY Change	69.71%	68.93%	68.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$65.99M	$59.92M	$59.92M
YoY Change	33.72%	85.97%	85.97%
Accrued Expenses	$120.6M	$155.9M	$148.7M
YoY Change	73.7%	50.36%	39.64%
Deferred Revenue	$408.1M	$360.0M
YoY Change	24.93%	35.56%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$616.1M	$602.6M	$602.6M
YoY Change	30.9%	43.99%	43.99%
LONG-TERM LIABILITIES
Long-Term Debt	$674.7M	$674.0M	$674.0M
YoY Change
Other Long-Term Liabilities	$4.511M	$4.613M	$306.8M
YoY Change	-1.79%	-14.45%	38.8%
Total Long-Term Liabilities	$4.511M	$4.613M	$980.8M
YoY Change	-1.79%	-14.45%	343.72%
TOTAL LIABILITIES
Total Short-Term Liabilities	$616.1M	$602.6M	$602.6M
Total Long-Term Liabilities	$4.511M	$4.613M	$980.8M
Total Liabilities	$1.605B	$1.583B	$1.583B
YoY Change	147.81%	147.27%	147.27%
SHAREHOLDERS EQUITY
Retained Earnings	$302.2M	$257.0M
YoY Change	83.4%	133.91%
Common Stock	$1.262B	$1.175B
YoY Change	12.8%	7.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$155.9M	$155.9M
YoY Change	0.0%	0.0%
Treasury Stock Shares	$20.22M	$20.22M
Shareholders Equity	$1.403B	$1.268B	$1.268B
YoY Change
Total Liabilities & Shareholders Equity	$3.008B	$2.852B	$2.852B
YoY Change	69.71%	68.93%	68.93%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$45.14M	$29.18M	$147.1M
YoY Change	-17.74%	-315.98%	-345.16%
Depreciation, Depletion And Amortization	$6.689M	$6.210M	$24.38M
YoY Change	16.23%	17.75%	30.42%
Cash From Operating Activities	-$56.32M	$131.1M	$235.4M
YoY Change	-228.11%	914.08%	89.05%
INVESTING ACTIVITIES
Capital Expenditures	$8.513M	$11.70M	$55.80M
YoY Change	-50.21%	-185.89%	11.86%
Acquisitions			$2.104M
YoY Change			-90.6%
Other Investing Activities	-$64.04M	-$517.3M	-$774.9M
YoY Change	-1043.51%	-399.41%	-355.87%
Cash From Investing Activities	-$72.67M	-$529.0M	-$831.0M
YoY Change	602.3%	-432.38%	-429.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	37.99M	600.6M	598.1M
YoY Change	-2703.84%	-717.36%	-443.38%
NET CHANGE
Cash From Operating Activities	-56.32M	131.1M	235.4M
Cash From Investing Activities	-72.67M	-529.0M	-831.0M
Cash From Financing Activities	37.99M	600.6M	598.1M
Net Change In Cash	-90.23M	202.7M	-886.0K
YoY Change	-381.96%	171.03%	-100.44%
FREE CASH FLOW
Cash From Operating Activities	-$56.32M	$131.1M	$235.4M
Capital Expenditures	$8.513M	$11.70M	$55.80M
Free Cash Flow	-$64.84M	$119.4M	$179.6M
YoY Change	-341.33%	349.8%	140.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount	103890000
	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount	1485000
	axon	Equity Securities Without Readily Determinable Fair Value Exercises EquitySecuritiesWithoutReadilyDeterminableFairValueExercises	66630000
	axon	Equity Securities Without Readily Determinable Fair Value Sales EquitySecuritiesWithoutReadilyDeterminableFairValueSales	14546000
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.575
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.726
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001069183
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	71474581
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	70896856
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-16391
CY2022	dei	Entity Registrant Name EntityRegistrantName	Axon Enterprise, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1805278000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1109490000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	169843000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	138457000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	156866000
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	127193000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12158000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15470000
CY2022Q4	us-gaap	Goodwill Goodwill	44983000
CY2021Q4	us-gaap	Goodwill Goodwill	43592000
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	156207000
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	31232000
CY2022Q4	us-gaap	Long Term Accounts Notes And Loans Receivable Net Noncurrent LongTermAccountsNotesAndLoansReceivableNetNoncurrent	5210000
CY2021Q4	us-gaap	Long Term Accounts Notes And Loans Receivable Net Noncurrent LongTermAccountsNotesAndLoansReceivableNetNoncurrent	11256000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	32220000
CY2022Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	45170000
CY2021Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	29753000
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	296563000
CY2021Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	83520000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	159616000
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-0741227
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	17800 North 85th Street
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85255
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Scottsdale
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
CY2022	dei	City Area Code CityAreaCode	480
CY2022	dei	Local Phone Number LocalPhoneNumber	991-0797
CY2022	dei	Security12b Title Security12bTitle	Common Stock, $0.00001 par value per share
CY2022	dei	Trading Symbol TradingSymbol	AXON
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	6300000000
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	72862227
CY2022	dei	Auditor Firm AuditorFirmId	248
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	353684000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	356332000
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	39240000
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	72180000
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	581769000
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	14510000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2176000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2203000
CY2022Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	358190000
CY2021Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	320819000
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	196902000
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	180421000
CY2022Q4	us-gaap	Inventory Net InventoryNet	202471000
CY2021Q4	us-gaap	Inventory Net InventoryNet	108688000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	98247000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	73022000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	56540000
CY2022Q4	us-gaap	Assets Assets	2851894000
CY2021Q4	us-gaap	Assets Assets	1688210000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	59918000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	155934000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	103707000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	360037000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	265591000
CY2022Q4	axon	Customer Deposit Current CustomerDepositCurrent	20399000
CY2021Q4	axon	Customer Deposit Current CustomerDepositCurrent	10463000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6358000
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6540000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	602646000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	418521000
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	248003000
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	185721000
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	10745000
CY2021Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	3797000
CY2022Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	6285000
CY2021Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	5679000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	811000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	37143000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	20440000
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	673967000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4613000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5392000
CY2022Q4	us-gaap	Liabilities Liabilities	1583403000
CY2021Q4	us-gaap	Liabilities Liabilities	640361000
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71474581
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	70896856
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1174594000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1095229000
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	20220227
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	20220227
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	155947000
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	155947000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	257022000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	109883000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7179000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	322471000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1317000
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	264672000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1268491000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1047849000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2851894000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1688210000
CY2022	us-gaap	Gross Profit GrossProfit	728638000
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	307286000
CY2021	us-gaap	Gross Profit GrossProfit	540910000
CY2020	us-gaap	Gross Profit GrossProfit	416331000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	401575000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	515007000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1189935000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	863381000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	681003000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	461297000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	233810000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	194026000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	123195000
CY2022	us-gaap	Operating Expenses OperatingExpenses	635385000
CY2021	us-gaap	Operating Expenses OperatingExpenses	709033000
CY2020	us-gaap	Operating Expenses OperatingExpenses	430481000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	93253000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-168123000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-14150000
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	103265000
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	26748000
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	7859000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	196518000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-141375000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6291000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	49379000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-81357000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4567000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	147139000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-60018000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1724000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.07
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.03
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71093000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66191000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61782000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	72534000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	66191000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61782000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	147139000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-60018000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1724000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4818000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1251000
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1237000
CY2022	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-1044000
CY2021	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-207000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	141277000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-61476000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-487000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	543495000
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	306779000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	-7514000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	133572000
CY2020	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1050000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1724000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1237000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	976255000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	105514000
CY2022	axon	Credit Loss Reserve CreditLossReserve	699000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	-331309000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	51614000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	303331000
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	3920000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-60018000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1458000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1047849000
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-74000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	-4870000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	106176000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	48858000
CY2022	axon	Adjustments To Additional Paid In Capital Purchase Of Convertible Note Hedge AdjustmentsToAdditionalPaidInCapitalPurchaseOfConvertibleNoteHedge	194994000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	124269000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	147139000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-5862000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1268491000
CY2022	us-gaap	Profit Loss ProfitLoss	147139000
CY2021	us-gaap	Profit Loss ProfitLoss	-60018000
CY2020	us-gaap	Profit Loss ProfitLoss	-1724000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24381000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18694000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12475000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	198000
CY2022	axon	Payment Of Coupon Interest PaymentOfCouponInterest	211000
CY2022	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	58000
CY2022	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-110000
CY2021	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-146000
CY2020	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-320000
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-5452000
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-92000
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1722000
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	98943000
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	23035000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	106176000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	303331000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	133572000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	22090000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-81303000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-16528000
CY2022	axon	Provision For Unrecognized Tax Benefits ProvisionForUnrecognizedTaxBenefits	3475000
CY2021	axon	Provision For Unrecognized Tax Benefits ProvisionForUnrecognizedTaxBenefits	-706000
CY2020	axon	Provision For Unrecognized Tax Benefits ProvisionForUnrecognizedTaxBenefits	671000
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-1463000
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5217000
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3345000
CY2022	axon	Non Cash Lease Expense NonCashLeaseExpense	6725000
CY2021	axon	Non Cash Lease Expense NonCashLeaseExpense	5573000
CY2020	axon	Non Cash Lease Expense NonCashLeaseExpense	4104000
CY2021	axon	Credit Loss Reserve CreditLossReserve	-214000
CY2020	axon	Credit Loss Reserve CreditLossReserve	1302000
CY2022	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	73228000
CY2021	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	205769000
CY2020	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	107762000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	95987000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	18272000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	52156000
CY2022	axon	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	52207000
CY2021	axon	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	40158000
CY2020	axon	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	14885000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	80757000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	45301000
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8886000
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	159718000
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	175615000
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	65139000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	235361000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	124494000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	38481000
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	764374000
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	362479000
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	656522000
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	72138000
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	718617000
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	379839000
CY2022	axon	Payments On Exercise Of Warrants Of Strategic Investment PaymentsOnExerciseOfWarrantsOfStrategicInvestment	6555000
CY2021	axon	Proceeds From Equity Securities Without Readily Determinable Fair Value ProceedsFromEquitySecuritiesWithoutReadilyDeterminableFairValue	14546000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	55802000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	49886000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	72629000
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	287000
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	43000
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	95000
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	307000
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	392000
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	241000
CY2022	axon	Payments To Acquire Equity Securities Without Readily Determinable Fair Value PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue	74250000
CY2021	axon	Payments To Acquire Equity Securities Without Readily Determinable Fair Value PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue	45500000
CY2020	axon	Payments To Acquire Equity Securities Without Readily Determinable Fair Value PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue	7068000
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2104000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	22393000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-830967000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	252556000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-356526000
CY2022	axon	Net Proceeds From Equity Offering NetProceedsFromEquityOffering	-74000
CY2021	axon	Net Proceeds From Equity Offering NetProceedsFromEquityOffering	105514000
CY2020	axon	Net Proceeds From Equity Offering NetProceedsFromEquityOffering	306779000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	51614000
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	295000
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4870000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	331309000
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	7809000
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	673769000
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	124269000
CY2022	us-gaap	Payments For Hedge Financing Activities PaymentsForHedgeFinancingActivities	194994000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	598100000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-174181000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	299265000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3380000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1982000
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1976000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-886000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	200887000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16804000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	356438000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	155551000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	172355000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	355552000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	356438000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	155551000
CY2021	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff	0
CY2022	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff	0
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	1900000
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	100000
CY2022Q4	axon	Restricted Cash Including Prepaid Expenses And Other Assets RestrictedCashIncludingPrepaidExpensesAndOtherAssets	1800000
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5300000
CY2022	axon	Number Of Revenue Sources NumberOfRevenueSources	2
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3600000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3300000
CY2022	axon	Warranty Period After Purchase Of Product WarrantyPeriodAfterPurchaseOfProduct	P1Y
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	2822000
CY2020Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	769000
CY2019Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1476000
CY2022	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	2209000
CY2021	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	873000
CY2020	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	700000
CY2022	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	198000
CY2021	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	2926000
CY2020	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-7000
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	811000
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	2822000
CY2020Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	769000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	233800000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	194000000.0
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	123200000
CY2022	axon	Number Of Depository Institutions NumberOfDepositoryInstitutions	3
CY2022Q4	axon	Cash And Cash Equivalents Held At Depository Institutions With Significant Concentrations CashAndCashEquivalentsHeldAtDepositoryInstitutionsWithSignificantConcentrations	139900000
CY2022	axon	Number Of Depository Institutions NumberOfDepositoryInstitutions	3
CY2022Q4	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	4300000
CY2021Q4	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	5300000
CY2022Q4	axon	Debt Instrument Principal Amount Denomination For Fair Value Calculation DebtInstrumentPrincipalAmountDenominationForFairValueCalculation	1000
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022	us-gaap	Net Income Loss NetIncomeLoss	147139000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-60018000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1189935000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1724000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71093000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66191000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61782000
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1441000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	72534000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	66191000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61782000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.07
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.03
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9298000
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7690000
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12150000
CY2022	us-gaap	Reclassifications Reclassifications	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Reclassification of Prior Year Presentation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:21.6pt;margin:0pt 0pt 12pt 0pt;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications are not material and had no effect on the reported results of operations.</p>
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	863381000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	681003000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1189935000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	863381000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	681003000
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	8900000
CY2022	axon	Revenue From Contract With Customer Payment Due Date From Date Of Invoice RevenueFromContractWithCustomerPaymentDueDateFromDateOfInvoice	P30D
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	242072000
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	210174000
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	84044000
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	608040000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	451312000
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	275181000
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	261271000
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	177812000
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	135513000
CY2022	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	31900000
CY2022	axon	Increase In Contract With Customer Asset Percentage IncreaseInContractWithCustomerAssetPercentage	0.152
CY2022	axon	Increase In Contract With Customer Liability IncreaseInContractWithCustomerLiability	156700000
CY2022	axon	Increase In Contract With Customer Liability Percentage IncreaseInContractWithCustomerLiabilityPercentage	0.347
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	360037000
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	248003000
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	608040000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	265591000
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	185721000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	451312000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	360037000
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	248003000
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	608040000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	265591000
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	185721000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	451312000
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4600000000
CY2022Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	29405000
CY2021Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	19962000
CY2022Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	93213000
CY2021Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	54028000
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	122618000
CY2021Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	73990000
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1183222000
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	57000
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	52379000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1130900000
CY2022Q4	axon	Cash Cash Equivalent And Investments Amortized Cost CashCashEquivalentAndInvestmentsAmortizedCost	353684000
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	39240000
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	581769000
CY2022Q4	axon	Long Term Investment LongTermInvestment	156207000
CY2022	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	349600000
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-32900000
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	492350000
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	5000
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	18101000
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	474254000
CY2021Q4	axon	Cash Cash Equivalent And Investments Amortized Cost CashCashEquivalentAndInvestmentsAmortizedCost	356332000
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	72180000
CY2021Q4	axon	Short Term Investment ShortTermInvestment	14510000
CY2021Q4	axon	Long Term Investment LongTermInvestment	31232000
CY2021	us-gaap	Debt Securities Held To Maturity Sold Amount DebtSecuritiesHeldToMaturitySoldAmount	165400000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3349000
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3376000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	700000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-46000
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	416000
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	54000
CY2022	axon	Allowance For Doubtful Accounts Receivable Other AllowanceForDoubtfulAccountsReceivableOther	-3000
CY2021	axon	Allowance For Doubtful Accounts Receivable Other AllowanceForDoubtfulAccountsReceivableOther	73000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3630000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3349000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2176000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2203000
CY2022Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	1360000
CY2021Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	1010000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	94000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	136000
CY2022Q4	axon	Allowance For Expected Credit Losses On Customer Receivables AllowanceForExpectedCreditLossesOnCustomerReceivables	3630000
CY2021Q4	axon	Allowance For Expected Credit Losses On Customer Receivables AllowanceForExpectedCreditLossesOnCustomerReceivables	3349000
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	72740000
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	38267000
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	129731000
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	70421000
CY2022Q4	us-gaap	Inventory Net InventoryNet	202471000
CY2021Q4	us-gaap	Inventory Net InventoryNet	108688000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	247738000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	197241000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	77895000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	58784000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	169843000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	138457000
CY2022	us-gaap	Depreciation Depreciation	20400000
CY2021	us-gaap	Depreciation Depreciation	15800000
CY2020	us-gaap	Depreciation Depreciation	9200000
CY2021Q4	us-gaap	Goodwill Goodwill	43592000
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1674000
CY2022	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	58000
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-225000
CY2022Q4	us-gaap	Goodwill Goodwill	44983000
	axon	Equity Securities Without Readily Determinable Fair Value Gain On Sale Of Securities EquitySecuritiesWithoutReadilyDeterminableFairValueGainOnSaleOfSecurities	12312000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	31068000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	20729000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10339000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	30733000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16966000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13767000
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1819000
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1819000
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1703000
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1703000
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	32887000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	20729000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12158000
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	32436000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16966000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15470000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4000000.0
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2900000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3300000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3786000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3722000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	887000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	688000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	354000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	902000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10339000
CY2021Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	83520000
CY2020Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	11711000
CY2022	axon	Equity Securities Without Readily Determinable Fair Value Purchases EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases	74606000
CY2021	axon	Equity Securities Without Readily Determinable Fair Value Purchases EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases	45500000
CY2021	axon	Equity Securities Without Readily Determinable Fair Value Gain On Sale Of Securities EquitySecuritiesWithoutReadilyDeterminableFairValueGainOnSaleOfSecurities	12312000
CY2022	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount	72915000
CY2021	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount	28543000
CY2022	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount	1108000
CY2022	axon	Equity Securities Without Readily Determinable Fair Value Exercises EquitySecuritiesWithoutReadilyDeterminableFairValueExercises	66630000
CY2021	axon	Equity Securities Without Readily Determinable Fair Value Sales EquitySecuritiesWithoutReadilyDeterminableFairValueSales	14546000
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	296563000
CY2021Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	83520000
	axon	Equity Securities Without Readily Determinable Fair Value Purchases EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases	129762000
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	296563000
CY2022	axon	Strategic Investments Exercise Of Warrants StrategicInvestmentsExerciseOfWarrants	6600000
CY2022	axon	Strategic Investments Unrealized Gain Loss On Exercise Of Warrants StrategicInvestmentsUnrealizedGainLossOnExerciseOfWarrants	60100000
CY2022Q4	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	4274000
CY2021Q4	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	5276000
CY2022Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	93213000
CY2021Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	54028000
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	54000
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	57000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	38370000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23270000
CY2022Q4	axon	Deferred Implementation Costs DeferredImplementationCosts	3045000
CY2021Q4	axon	Deferred Implementation Costs DeferredImplementationCosts	3915000
CY2022Q4	axon	Prepaid Expenses Deposits And Other Assets Noncurrent PrepaidExpensesDepositsAndOtherAssetsNoncurrent	20660000
CY2021Q4	axon	Prepaid Expenses Deposits And Other Assets Noncurrent PrepaidExpensesDepositsAndOtherAssetsNoncurrent	11701000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	159616000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	98247000
CY2021	axon	Deferred Implementation Costs Assets Placed Into Service DeferredImplementationCostsAssetsPlacedIntoService	4300000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	97882000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	62425000
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3861000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	7152000
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	811000
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	2822000
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	13559000
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	3736000
CY2022Q4	axon	Accrued Inventory In Transit Current AccruedInventoryInTransitCurrent	10548000
CY2021Q4	axon	Accrued Inventory In Transit Current AccruedInventoryInTransitCurrent	9945000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	29273000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	17627000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	155934000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	103707000
CY2022	us-gaap	Debt Instrument Sinking Fund Payment DebtInstrumentSinkingFundPayment	0
CY2022Q4	axon	Amount Of Open Purchase Orders AmountOfOpenPurchaseOrders	499700000
CY2022Q4	axon	Other Purchase Obligation OtherPurchaseObligation	415400000
CY2022Q4	us-gaap	Loss Contingency Pending Claims Number LossContingencyPendingClaimsNumber	4
CY2022	axon	Product Claims Self Insurance ProductClaimsSelfInsurance	5000000.0
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	191631000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-146995000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-11529000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	4887000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	5620000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	5238000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	196518000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-141375000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6291000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	10804000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-331000
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	5277000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	10118000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	85000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3886000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	2892000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-60000
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1943000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	23814000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-306000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	11106000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	478000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	26238000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-65557000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-10175000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2002000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-15266000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3111000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2146000
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-3131000
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.251
CY2022	axon	Deferred Income Tax Expense Benefit Including Differencefor Revenue Recognition Adoption DeferredIncomeTaxExpenseBenefitIncludingDifferenceforRevenueRecognitionAdoption	22090000
CY2021	axon	Deferred Income Tax Expense Benefit Including Differencefor Revenue Recognition Adoption DeferredIncomeTaxExpenseBenefitIncludingDifferenceforRevenueRecognitionAdoption	-80345000
CY2020	axon	Deferred Income Tax Expense Benefit Including Differencefor Revenue Recognition Adoption DeferredIncomeTaxExpenseBenefitIncludingDifferenceforRevenueRecognitionAdoption	-16417000
CY2022	axon	Tax Impact Of Unrecorded Tax Liability Benefits1 TaxImpactOfUnrecordedTaxLiabilityBenefits1	3475000
CY2021	axon	Tax Impact Of Unrecorded Tax Liability Benefits1 TaxImpactOfUnrecordedTaxLiabilityBenefits1	-706000
CY2020	axon	Tax Impact Of Unrecorded Tax Liability Benefits1 TaxImpactOfUnrecordedTaxLiabilityBenefits1	744000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	49379000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-81357000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4567000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	41283000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-29691000
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1321000
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	7928000
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-12717000
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	935000
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-428000
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-155000
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-86000
CY2022	axon	Income Tax Reconciliation Other Permanent Difference IncomeTaxReconciliationOtherPermanentDifference	1771000
CY2021	axon	Income Tax Reconciliation Other Permanent Difference IncomeTaxReconciliationOtherPermanentDifference	1842000
CY2020	axon	Income Tax Reconciliation Other Permanent Difference IncomeTaxReconciliationOtherPermanentDifference	794000
CY2022	axon	Income Tax Reconciliation Foreign Derived Intangible Income Deduction IncomeTaxReconciliationForeignDerivedIntangibleIncomeDeduction	-2597000
CY2020	axon	Income Tax Reconciliation Foreign Derived Intangible Income Deduction IncomeTaxReconciliationForeignDerivedIntangibleIncomeDeduction	-902000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	5784000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	180509000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	15463000
CY2022	axon	Income Tax Reconciliation Deductions Research IncomeTaxReconciliationDeductionsResearch	13340000
CY2021	axon	Income Tax Reconciliation Deductions Research IncomeTaxReconciliationDeductionsResearch	34376000
CY2020	axon	Income Tax Reconciliation Deductions Research IncomeTaxReconciliationDeductionsResearch	10246000
CY2022	axon	Income Tax Reconciliation Return To Provision Adjustment IncomeTaxReconciliationReturnToProvisionAdjustment	-757000
CY2021	axon	Income Tax Reconciliation Return To Provision Adjustment IncomeTaxReconciliationReturnToProvisionAdjustment	204000
CY2020	axon	Income Tax Reconciliation Return To Provision Adjustment IncomeTaxReconciliationReturnToProvisionAdjustment	-1078000
CY2022	axon	Income Tax Reconciliation Change In Liability For Unrecognized Tax Benefits IncomeTaxReconciliationChangeInLiabilityForUnrecognizedTaxBenefits	3215000
CY2021	axon	Income Tax Reconciliation Change In Liability For Unrecognized Tax Benefits IncomeTaxReconciliationChangeInLiabilityForUnrecognizedTaxBenefits	10188000
CY2020	axon	Income Tax Reconciliation Change In Liability For Unrecognized Tax Benefits IncomeTaxReconciliationChangeInLiabilityForUnrecognizedTaxBenefits	987000
CY2022	axon	Income Tax Reconciliation Deduction IncomeTaxReconciliationDeduction	4616000
CY2021	axon	Income Tax Reconciliation Deduction IncomeTaxReconciliationDeduction	205483000
CY2020	axon	Income Tax Reconciliation Deduction IncomeTaxReconciliationDeduction	9002000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	10216000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	8961000
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	163000
CY2022	axon	Effective Income Tax Rate Reconciliation Tax Effect Of Intercompany Transactions1 EffectiveIncomeTaxRateReconciliationTaxEffectOfIntercompanyTransactions1	-417000
CY2021	axon	Effective Income Tax Rate Reconciliation Tax Effect Of Intercompany Transactions1 EffectiveIncomeTaxRateReconciliationTaxEffectOfIntercompanyTransactions1	96000
CY2020	axon	Effective Income Tax Rate Reconciliation Tax Effect Of Intercompany Transactions1 EffectiveIncomeTaxRateReconciliationTaxEffectOfIntercompanyTransactions1	-389000
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1337000
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-735000
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	115000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	49379000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4567000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-81357000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4874000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	68353000
CY2022Q4	axon	Deferred Tax Assets Deferred Warranty Revenue DeferredTaxAssetsDeferredWarrantyRevenue	47586000
CY2021Q4	axon	Deferred Tax Assets Deferred Warranty Revenue DeferredTaxAssetsDeferredWarrantyRevenue	27031000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	1575000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	1414000
CY2022Q4	axon	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	9973000
CY2021Q4	axon	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	5886000
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1279000
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	684000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	15374000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	10913000
CY2022Q4	axon	Deferred Tax Assets Amortization DeferredTaxAssetsAmortization	2820000
CY2021Q4	axon	Deferred Tax Assets Amortization DeferredTaxAssetsAmortization	2672000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	12826000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	29249000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	17732000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	14717000
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	46122000
CY2022Q4	axon	Deferred Tax Assets Convertible Debt Net DeferredTaxAssetsConvertibleDebtNet	48378000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	208539000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	160919000
CY2022Q4	axon	Deferred Tax Liabilities Customer Contract Asset DeferredTaxLiabilitiesCustomerContractAsset	552000
CY2021Q4	axon	Deferred Tax Liabilities Customer Contract Asset DeferredTaxLiabilitiesCustomerContractAsset	1104000
CY2022Q4	axon	Deferred Tax Liabilities Rightofuse Asset DeferredTaxLiabilitiesRightofuseAsset	8748000
CY2021Q4	axon	Deferred Tax Liabilities Rightofuse Asset DeferredTaxLiabilitiesRightofuseAsset	5008000
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	10272000
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	8938000
CY2022Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	4615000
CY2021Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	2653000
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	1119000
CY2021Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	594000
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	72000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	25306000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	18369000
CY2022Q4	axon	Deferred Tax Assets Net Of Deferred Tax Liabilities1 DeferredTaxAssetsNetOfDeferredTaxLiabilities1	183233000
CY2021Q4	axon	Deferred Tax Assets Net Of Deferred Tax Liabilities1 DeferredTaxAssetsNetOfDeferredTaxLiabilities1	142550000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	26368000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16168000
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	156865000
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	126382000
CY2022Q4	axon	Research And Development Tax Credit Carryforwards Subject To Limitation Federal ResearchAndDevelopmentTaxCreditCarryforwardsSubjectToLimitationFederal	100000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	21500000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	21500000
CY2021Q4	axon	Unrecognized Tax Benefit Net Of Interest On Income Taxes Accrued1 UnrecognizedTaxBenefitNetOfInterestOnIncomeTaxesAccrued1	18249000
CY2020Q4	axon	Unrecognized Tax Benefit Net Of Interest On Income Taxes Accrued1 UnrecognizedTaxBenefitNetOfInterestOnIncomeTaxesAccrued1	7657000
CY2019Q4	axon	Unrecognized Tax Benefit Net Of Interest On Income Taxes Accrued1 UnrecognizedTaxBenefitNetOfInterestOnIncomeTaxesAccrued1	6861000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	232000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	22000
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	34000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	3343000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	11416000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	950000
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	332000
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	846000
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	120000
CY2022Q4	axon	Unrecognized Tax Benefit Net Of Interest On Income Taxes Accrued1 UnrecognizedTaxBenefitNetOfInterestOnIncomeTaxesAccrued1	21492000
CY2021Q4	axon	Unrecognized Tax Benefit Net Of Interest On Income Taxes Accrued1 UnrecognizedTaxBenefitNetOfInterestOnIncomeTaxesAccrued1	18249000
CY2020Q4	axon	Unrecognized Tax Benefit Net Of Interest On Income Taxes Accrued1 UnrecognizedTaxBenefitNetOfInterestOnIncomeTaxesAccrued1	7657000
CY2022Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	300000
CY2021Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	200000
CY2022	axon	Debt Instrument Covenant Consolidated Leverage Ratio DebtInstrumentCovenantConsolidatedLeverageRatio	0.97
CY2022	axon	Number Of Classes Of Stock NumberOfClassesOfStock	2
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2700000
CY2018Q2	axon	Market Capitalization Goal For Tranche First Tranche MarketCapitalizationGoalForTrancheFirstTranche	2500000000
CY2018Q2	axon	Market Capitalization Goal For Tranche Incremental Increase MarketCapitalizationGoalForTrancheIncrementalIncrease	1000000000.0
CY2022Q4	axon	Revenue Goal Goal Number One RevenueGoalGoalNumberOne	710058000
CY2022Q4	axon	Adjusted Ebitda Goal Goal Number One AdjustedEbitdaGoalGoalNumberOne	125000000
CY2022Q4	axon	Revenue Goal Goal Number Two RevenueGoalGoalNumberTwo	860058000
CY2022Q4	axon	Adjusted Ebitda Goal Goal Number Two AdjustedEbitdaGoalGoalNumberTwo	155000000
CY2022Q4	axon	Revenue Goal Goal Number Three RevenueGoalGoalNumberThree	1010058000
CY2022Q4	axon	Adjusted Ebitda Goal Goal Number Three AdjustedEbitdaGoalGoalNumberThree	175000000
CY2022Q4	axon	Revenue Goal Goal Number Four RevenueGoalGoalNumberFour	1210058000
CY2022Q4	axon	Adjusted Ebitda Goal Goal Number Four AdjustedEbitdaGoalGoalNumberFour	190000000
CY2022Q4	axon	Revenue Goal Goal Number Five RevenueGoalGoalNumberFive	1410058000
CY2022Q4	axon	Adjusted Ebitda Goal Goal Number Five AdjustedEbitdaGoalGoalNumberFive	200000000
CY2022Q4	axon	Revenue Goal Goal Number Six RevenueGoalGoalNumberSix	1610058000
CY2022Q4	axon	Adjusted Ebitda Goal Goal Number Six AdjustedEbitdaGoalGoalNumberSix	210000000
CY2022Q4	axon	Revenue Goal Goal Number Seven RevenueGoalGoalNumberSeven	1810058000
CY2022Q4	axon	Adjusted Ebitda Goal Goal Number Seven AdjustedEbitdaGoalGoalNumberSeven	220000000
CY2022Q4	axon	Revenue Goal Goal Number Eight RevenueGoalGoalNumberEight	2010058000
CY2022Q4	axon	Adjusted Ebitda Goal Goal Number Eight AdjustedEbitdaGoalGoalNumberEight	230000000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	243900000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1100000
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1100000
CY2021	us-gaap	Lease Cost LeaseCost	7495000
CY2020	us-gaap	Lease Cost LeaseCost	6702000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	106176000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	303331000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	133572000
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	25154000
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	30586000
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	29329000
CY2022Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2022	axon	Lessee Operating Lease Termination Period LesseeOperatingLeaseTerminationPeriod	P1Y
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	0
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	38370000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23270000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6357000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6540000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	37143000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	20440000
CY2022Q4	axon	Lessee Lease Liability LesseeLeaseLiability	43500000
CY2021Q4	axon	Lessee Lease Liability LesseeLeaseLiability	26980000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	8703000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	7495000
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	6757000
CY2020	us-gaap	Sublease Income SubleaseIncome	55000
CY2022	us-gaap	Lease Cost LeaseCost	8703000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	9216000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	7506000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	21815000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6726000
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y2M12D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y2M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0544
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0273
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	155440000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1868000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	8448000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	8936000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8990000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5374000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	3566000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	20579000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	55893000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	12393000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	43500000
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	10900000
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	7400000
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	5600000
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1189935000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	461297000
CY2022	us-gaap	Gross Profit GrossProfit	728638000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	233810000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	863381000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	322471000
CY2021	us-gaap	Gross Profit GrossProfit	540910000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	194026000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	681003000
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	264672000
CY2020	us-gaap	Gross Profit GrossProfit	416331000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	123195000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	353684000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	356332000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	106000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	111000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	355552000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	356438000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	155551000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	10508000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5108000
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	10893000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1056000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1994000
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	878000
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1	3920000
CY2022	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2022	dei	Auditor Location AuditorLocation	Phoenix, Arizona

Files In Submission

Name	View Source	Status
axon-20221231_pre.xml	Edgar Link	unprocessable
axon-20221231_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001558370-23-002413-index-headers.html	Edgar Link	pending
0001558370-23-002413-index.html	Edgar Link	pending
0001558370-23-002413.txt	Edgar Link	pending
0001558370-23-002413-xbrl.zip	Edgar Link	pending
axon-20221231.xsd	Edgar Link	pending
axon-20221231x10k.htm	Edgar Link	pending
axon-20221231x10k003.jpg	Edgar Link	pending
axon-20221231xex10d24.htm	Edgar Link	pending
axon-20221231xex10d24002.jpg	Edgar Link	pending
axon-20221231xex10d24003.jpg	Edgar Link	pending
axon-20221231xex21d1.htm	Edgar Link	pending
axon-20221231xex23d1.htm	Edgar Link	pending
axon-20221231xex31d1.htm	Edgar Link	pending
axon-20221231xex31d2.htm	Edgar Link	pending
axon-20221231xex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
axon-20221231x10k_htm.xml	Edgar Link	completed
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
axon-20221231_def.xml	Edgar Link	unprocessable
axon-20221231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AXON
AXON ENTERPRISE, INC. Stock $axon

2023 Q1 Form 10-K Financial Statement

#000155837023002413 Filed on February 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AXON AXON ENTERPRISE, INC. Stock $axon

2023 Q1 Form 10-K Financial Statement

#000155837023002413 Filed on February 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AXON
AXON ENTERPRISE, INC. Stock $axon